Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
1 189 EUR
1 402 EUR
1 215 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
35 088 EUR
3 177 EUR
26 720 EUR
Current assets
16 219 EUR
42 634 EUR
40 048 EUR
Non-current liabilities
10 429 EUR
10 646 EUR
23 918 EUR
Current liabilities
15 264 EUR
11 678 EUR
20 005 EUR
Profit (loss)
23 488 EUR
23 488 EUR
228,000 EUR
228,000 EUR
53 797 EUR
53 797 EUR
Other comprehensive income
164,000 EUR
49,000 EUR
213,000 EUR
422,000 EUR
235,000 EUR
187,000 EUR
68,000 EUR
528,000 EUR
460,000 EUR
Comprehensive income
23 652 EUR
23 488 EUR
49,000 EUR
EUR
213,000 EUR
EUR
EUR
194,000 EUR
235,000 EUR
228,000 EUR
EUR
187,000 EUR
53 797 EUR
EUR
68,000 EUR
528,000 EUR
EUR
54 257 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.